Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III Trial - risk factors and concomitance with hypertension

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 901-906

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Microwave Thermotherapy for Benign Prostatic Hyperplasia with the Dornier Urowave: Results of a Randomized, Double-blind, Multicenter, Sham-controlled Trial - how much change in AUA symptom index and the BPH impact index is perceptible to patients?

By Roehrborn C.G.   Preminger G.   Newhall P.   Denstedt J.   Razvi H.   Chin L.J.   Perlmutter A.   Barzell W.   Whitmore W.   Fritzsch R.   Sanders J.   Sech S.   Womack S.  

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 19-28

Elsevier

Access to resources Recommend Favorite

Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study

By Maria G.   Brisinda G.   Civello I.M.   Bentivoglio A.R.   Sganga G.   Albanese A.  

Urology, Vol. 62, Iss. 2, 2003-08 ,pp. : 259-264

Elsevier

Access to resources Recommend Favorite

Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study

By Lee Seung   Byun Seok   Lee Seung   Kim Khae   Lee Ji  

International Urology and Nephrology, Vol. 46, Iss. 3, 2014-03 ,pp. : 523-529

Springer Publishing Company

Access to resources Recommend Favorite